Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Nature Medicine 14, 918–919 (1 September 2008) | doi:10.1038/nm0908-918
Counteracting clotting in sepsis
Abstract
Acute bacterial infection leading to sepsis affects over half a million individuals annually in the United States. Available therapies have been primarily supportive, and mortality rates still hover at 30–50%.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
